Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

BACKGROUND: Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between metaplastic breast cancer and triple-negative...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Morgan, Evan, Suresh, Anupama, Ganju, Akaansha, Stover, Daniel G., Wesolowski, Robert, Sardesai, Sagar, Noonan, Anne, Reinbolt, Raquel, VanDeusen, Jeffrey, Williams, Nicole, Cherian, Mathew A., Li, Zaibo, Young, Gregory, Palettas, Marilly, Stephens, Julie, Liu, Joseph, Luff, Amanda, Ramaswamy, Bhuvaneswari, Lustberg, Maryam
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961248/
https://ncbi.nlm.nih.gov/pubmed/31937323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-019-1780-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados